GGHC
ABMD

Gilder Gagnon Howe & Co’s Abiomed Inc ABMD Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-47,316
Closed -$11.6M – 272
2022
Q3 		$11.6M Buy
47,316
+100
+0.2% +$27K 0.2% 97
2022
Q2 		$11.7M Sell
47,216
-4,946
-9% -$1.33M 0.21% 100
2022
Q1 		$17.3M Sell
52,162
-114,810
-69% -$35.3M 0.16% 116
2021
Q4 		$60M Sell
166,972
-885
-0.5% -$299K 0.34% 79
2021
Q3 		$54.6M Sell
167,857
-1,093
-0.6% -$370K 0.28% 86
2021
Q2 		$52.7M Sell
168,950
-11,401
-6% -$3.5M 0.26% 99
2021
Q1 		$57.5M Buy
180,351
+53,502
+42% +$17.1M 0.31% 87
2020
Q4 		$41.1M Sell
126,849
-1,325
-1% -$366K 0.2% 113
2020
Q3 		$35.5M Sell
128,174
-1,919
-1% -$553K 0.22% 107
2020
Q2 		$31.4M Sell
130,093
-7,638
-6% -$1.53M 0.25% 102
2020
Q1 		$20M Sell
137,731
-11,443
-8% -$1.9M 0.24% 99
2019
Q4 		$25.4M Buy
149,174
+294
+0.2% +$54.5K 0.26% 90
2019
Q3 		$26.5M Sell
148,880
-20,204
-12% -$4.37M 0.3% 89
2019
Q2 		$44M Sell
169,084
-49,480
-23% -$13.1M 0.44% 70
2019
Q1 		$62.4M Sell
218,564
-2,637
-1% -$876K 0.67% 53
2018
Q4 		$71.9M Buy
221,201
+9,570
+5% +$3.32M 1.02% 31
2018
Q3 		$95.2M Buy
211,631
+14,681
+7% +$5.79M 0.97% 34
2018
Q2 		$80.6M Buy
196,950
+36,371
+23% +$13.2M 0.87% 39
2018
Q1 		$46.7M Buy
160,579
+140,728
+709% +$35.7M 0.58% 56
2017
Q4 		$3.72M Buy
19,851
+4,803
+32% +$897K 0.05% 176
2017
Q3 		$2.54M Sell
15,048
-299
-2% -$45.2K 0.04% 180
2017
Q2 		$2.2M Buy
15,347
+446
+3% +$59.9K 0.03% 176
2017
Q1 		$1.87M Sell
14,901
-722
-5% -$83.7K 0.03% 176
2016
Q4 		$1.76M Buy
15,623
+7,351
+89% +$852K 0.03% 167
2016
Q3 		$1.06M Buy
8,272
+6,303
+320% +$755K 0.02% 188
2016
Q2 		$215K Buy
1,969
+67
+4% +$6.67K ﹤0.01% 226
2016
Q1 		$180K Sell
1,902
-32
-2% -$2.7K ﹤0.01% 200
2015
Q4 		$175K Sell
1,934
-5,272
-73% -$447K ﹤0.01% 213
2015
Q3 		$668K Buy
+7,206
New +$635K 0.01% 197

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Gilder Gagnon Howe & Co's ABMD Position: Q4 2022 in Review

Gilder Gagnon Howe & Co sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 47,316 shares — an estimated $11.6M sold.

Gilder Gagnon Howe & Co first reported a position in ABMD in Q3 2015 and held it in 29 quarters. The position peaked at $95.2M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Gilder Gagnon Howe & Co reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 47,316 Abiomed Inc shares in Q4 2022, an estimated $11.6M.
  • Gilder Gagnon Howe & Co first reported a position in Abiomed Inc in Q3 2015 and held it in 29 quarters.
  • Gilder Gagnon Howe & Co's Abiomed Inc position peaked at $95.2M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2022, filed 14 Feb 2023.